INTRODUCTION
Atrial fibrillation (AF) is the most common type of arrhythmia. In 2010, its global burden, which is progressively increasing, was more than 45 million cases [1] .
Although multiple theories about the etiology of AF have been previously proposed, the exact pathophysiological mechanism is unknown and is thought to be mostly multifactorial [2] .
In addition, many experts have reported that in at least 10% of the cases, no underlying cause is ever found, a condition that is known as lone AF [3] . The most common surgical treatment for all types of AF is based on the well-known Cox-Maze procedure. Although this procedure is quite successful and has had good long-term results, it is not considered curative. Nevertheless, many cardiothoracic surgeons, employing a number of modifications with a common lesion set, use the Cox-Maze procedure. This paper reviews the current methods of surgical treatment for AF and offers some suggestions on how treatment methods can be further developed to facilitate better outcomes.
DEFINITION AND DIAGNOSIS
AF is defined as an abnormal heart rhythm with the following characteristics on an electrocardiogram: (1) absolutely irregular RR intervals; (2) no distinct P waves, and (3) atrial cycle length (when visible) usually variable within 200 milliseconds (＞300 beats per minute) [4] . AF is confirmed diagnostically if the above characteristics last sufficiently long enough for a 12-lead echocardiogram to be recorded or for at least 30 seconds on a rhythm strip.
CLASSIFICATION
AF is classified based on presentation and duration. Many classifications have been adopted, but the most recent is that reported by the European Society of Cardiology (ESC) in 2010 as follows [4] . 2) Paroxysmal AF is self-terminating, usually within 48 hours. Although AF paroxysms may continue for up to 7 days, the 48-hour time point is clinically important-after this the likelihood of spontaneous conversion is low and anticoagulation must be considered.
3) Persistent AF is present when an AF episode either lasts longer than 7 days or requires termination by cardioversion, either with drugs or by direct current cardioversion.
4) Long-standing persistent AF has lasted for ≥1 year when it is decided to adopt a rhythm control strategy. 2) Nonvalvular AF refers to AF that occurs in the absence of rheumatic mitral valve disease, a prosthetic heart valve, or valve repair.
3) Secondary AF is a separate classification used in the context of acute myocardial infarctions, cardiac surgery, pericarditis, myocarditis, hyperthyroidism, or acute pulmonary disease. In these situations, AF is not the primary problem, and it is usually terminated with the concurrent treatment of the underlying disorder.
MEDICAL MANAGEMENT
Medical management differs according to whether the therapeutic goal is rhythm control or rate control. Rhythm control aims to restore and maintain sinus rhythm, whereas rate control allows AF to persist while attempting to control the ventricular rate response. The specific drugs used in the medical management of AF are listed in detail in the ACC/AHA/ESC guidelines [5] . In a review of these guidelines, the Atrial 
ROLE OF ANTICOAGULATION
Patients with AF have a risk for stroke approximately five times higher than those without AF, and AF is also known to cause an estimated 15% of all strokes [6, 7] . Oral anti- rates of major bleeding [8] . Rivaroxaban [9] , apixaban [10] , edoxaban [11] , and betrixaban [12] are examples of oral factor Xa inhibitors under development for the prevention of stroke.
OTHER NON-SURGICAL TREATMENT MODALITIES REFRACTORY TO MEDICATION
Direct-current cardioversion is a procedure to electrically convert an arrhythmia to a normal sinus rhythm. Electrical cardioversion is most frequently used to treat AF with hemodynamic instability that persists despite medication. It also can be used to treat almost any type of arrhythmia, including atrial flutter and ventricular tachycardia.
Radiofrequency catheter ablation is a procedure performed percutaneously through one or both femoral veins as an option for symptomatic patients with AF refractory to antiarrhythmic drugs or where medication is contraindicated [13] .
Although radiofrequency catheter ablation is known to be more effective than antiarrhythmic drugs [14] , the rate of sinus rhythm restoration is low with a high rate of recurrence and reintervention [15] .
While performing percutaneous transvenous catheter ablation, occlusion of the left atrial appendage (LAA) can be accomplished with devices such as the WATCHMAN [16] , PLAATO [17] , or the Amplatzer Cardiac Plug device [18] .
However, these devices have been associated with procedural complications such as pericardial effusion, incomplete appendage closure, dislodgement of the device, thrombus formation on the device, and air embolism due to the catheter-based technique [19, 20] . Despite the development of novel devices, internal occlusion of the LAA is very challenging due to its heterogeneous anatomy [21] .
SURGICAL MANAGEMENT
The Cox-Maze III procedure is the gold standard for the surgical treatment of AF. This procedure is usually performed concomitantly during open-heart surgery in AF patients with other valvular or coronary diseases through a median sternotomy. Another surgical approach is to perform a right thoracotomy for concomitant mitral valve surgery along with the maze procedure [22] .
The classical Cox-Maze III procedure, first introduced by Dr. James Cox in 1988, was performed in a cut-and-sew method using a biatrial lesion set [23] . This cut-and-sew procedure is rarely performed now since it requires extensive incisions over a prolonged period. This procedure was then modified using cryoablation to replace most of the cut-and-sew incisions of the lesion sets, resulting in the modified Cox-Maze III procedure [24] . Other than cryoablation, Cryoablation with argon or nitrous oxide is preferably used endocardially, while radiofrequency and high intensity focused ultrasound are used epicardially (radiofrequency can also be used endocardially) when performing the Cox-Maze III or IV procedure. Microwave energy can be applied either endocardially while performing other open-heart procedures or epicardially on the beating heart. However, transmurality cannot be guaranteed, and the results are variable with maintenance of sinus rhythm ranging from 42% to 81% one year after the procedure [26, 27] . High intensity focused ultrasound is a relatively new and promising energy source that can feasibly create transmural lesions either endocardially or epicardially, but a recent study has reported a low success rate with a high complication rate [28] .
Whichever energy source is used, the complete maze lesion set is not fully reproducible on the epicardial surface. To fully reproduce all maze lesions and further increase the success rate in minimally invasive approaches, a hybrid procedure of both surgical epicardial and percutaneous transvenous catheter ablation on the beating heart for lone AF has been introduced recently and can be performed simultaneously as a single-stage or two-stage procedure [29, 30] . 
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was reported. 
ACKNOWLEDGMENTS

